(Press-News.org) Contact information: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Brain cancer cells hide while drugs seek
Tumor cells temporarily lose mutation to evade drugs targeting mutation
A team of scientists, led by principal investigator Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine, has found that brain cancer cells resist therapy by dialing down the gene mutation targeted by drugs, then re-amplify that growth-promoting mutation after therapy has stopped.
The findings are published in the December 5, 2013 online issue of Science.
"This discovery has considerable clinical implications because if cancer cells can evade therapy by a 'hide-and-seek' mechanism, then the current focus (of drug therapies) is unlikely to translate into better outcomes for patients," said Mischel.
In recent years, new cancer therapies have emerged that target tell-tale gene mutations to identify specific cancer cells for destruction. Unfortunately, a variety of "resistance mechanisms" have also emerged, among them incomplete target suppression, second-site mutations and activation of alternative kinases or enzymes that maintain growth-promoting signals to the cancer itself.
"Most research is aimed at developing better drugs or better drug combinations to suppress these downstream signals," Mischel said. "However, one thing that has not been carefully considered is whether cancer cells can modulate the levels of – and thus their dependence on – the target of the drug, evade therapy, and then re-acquire the oncogene to promote tumor growth when the drug is withdrawn."
Mischel and colleagues, including Webster K. Cavenee, PhD, and Frank B. Furnari, PhD, of the Ludwig Institute and the UC San Diego School of Medicine, investigated the behavior of glioblastoma multiforme (GBM), the most common malignant primary brain cancer in adults. More than 9,000 new cases of the disease are diagnosed each year in the United States and effective treatments are limited. The tumors are aggressive and resistant to current therapies, such as surgery, radiation and chemotherapy. The median survival rate for newly diagnosed GBM patients is just 14 months.
GBM is characterized by a mutated variant of the epidermal growth factor receptor known as EGFRvIII that is found on extrachromosomal DNA in cancer cells. EGFRvIII promotes tumor growth. Some new drugs kill cancer cells by specifically suppressing or inhibiting EGFRvIII, but lose effectiveness as drug resistance soon develops.
The researchers found that this resistance may be due to the cancer cells temporarily dumping their extrachromosomal EGFRvIII, which essentially renders them invisible to drugs looking for that particular mutation. When the drug therapy is halted, the EGFRvIII reappears at previous levels and accelerated tumor growth resumes.
"This is, to the best of our knowledge, the first demonstration that reversible loss of an oncogene on extrachromosomal DNA can lead to targeted cancer drug resistance," said Mischel, who hoped the findings would "shift the discussion about what directions need to be taken to improve the success rate for targeted cancer treatments."
INFORMATION:
Co-authors include David A. Nathanson and Minori Ohashi, Department of Medical and Molecular Pharmacology, UCLA; Beatrice Gini, Tomoyuki Koga, German Gomez, Kenta Masui, Huijin Yang, Shaojun Zhu, Jill Wykosky and Rachel Reed, Ludwig Institute for Cancer Research, UCSD; Jack Mottahedeh and Koppany Visyei, NPI-Semel Institute for Neuroscience & Human Behavior, UCLA; Ascia Eskin and Stanley F. Nelson, Department of Human Genetics, UCLA; Kiwook Hwang, Jun Wang and James R. Heath, NanoSystems Biology Cancer Center, California Institute of Technology; Andres Paucar, Department of Medical and Molecular Pharmacology and NPI-Semel Institute for Neuroscience & Human Behavior, UCLA; Timothy F. Cloughesy, Henry Singleton Brain Tumor Program and Department of Neurology, UCLA; C. David James, UC San Francisco; P. Nagesh Rao, Department of Pathology and Laboratory Medicine, UCLA; and Harley I. Kornblum, Department of Medical and Molecular Pharmacology, NPI-Semel Institute for Neuroscience & Human Behavior and Henry Singleton Brain Tumor Program, UCLA.
Funding support came, in part, from The Ben and Catherine Ivy Foundation Fund, the National Institutes of Health (grants NS73831, U54 CA151819, P01-CA95616, R01-NS080939, NINDS R01 NS052563), the Ziering Family Foundation, Art of the Brain Fund, the James S. McDonnell Foundation, The European Commission, the Ruth L. Kirschstein Institutional National Research Service Award, the UCLA Scholars in Oncologic Molecular Imaging Program and the Ludwig Institute for Cancer Research.
Brain cancer cells hide while drugs seek
Tumor cells temporarily lose mutation to evade drugs targeting mutation
2013-12-06
ELSE PRESS RELEASES FROM THIS DATE:
Acute kidney injury may be more deadly than heart attacks
2013-12-06
Acute kidney injury may be more deadly than heart attacks
Improved prevention and therapy urgently needed
Washington, DC (December 5, 2013) — Acute kidney injury, a condition that is common but often asymptomatic, may be more deadly than a heart attack, according to a ...
Deep-sea study reveals cause of 2011 tsunami
2013-12-06
Deep-sea study reveals cause of 2011 tsunami
Drilling in Japan Trench by international scientific team finds unusually thin, slippery geological fault
The devastating tsunami that struck Japan's Tohoku region in March 2011 was touched off by a submarine ...
Cancer's game of hide-and-seek
2013-12-06
Cancer's game of hide-and-seek
Researchers describe a novel mechanism by which glioblastoma tumors resist targeted therapies
December 5, 2013, New York, NY– A Ludwig Cancer Research study has uncovered an entirely novel mechanism by which glioblastoma ...
Scientists calculate friction of Japan's 9.0 earthquake in 2011
2013-12-06
Scientists calculate friction of Japan's 9.0 earthquake in 2011
CORVALLIS, Ore. – An international team of scientists that installed a borehole temperature observatory following the 2011 Tohoku-Oki earthquake in Japan has been able to measure the "frictional ...
Cancer mutation likely trigger of scleroderma
2013-12-06
Cancer mutation likely trigger of scleroderma
Findings could reshape research on cancer origins and treatment of other autoimmune diseases
Johns Hopkins scientists have found evidence that cancer triggers the autoimmune disease scleroderma, which causes thickening and ...
7 world-class cities riding tall in bike-share boom, solving 'the last mile' without cars
2013-12-06
PUBLIC RELEASE DATE: 5-Dec-2013
[
| E-mail
]
var addthis_pub="eurekalert"; var addthis_options = "favorites, delicious, digg, facebook, twitter, google, newsvine, reddit, slashdot, stumbleupon, buzz, more"
Share
Contact: Jemilah Magnusson
jemilah.magnusson@itdp.org
646-380-2357
Dan Klotz
dklotz@burnesscommunications.com
301-280-5756
Burness Communications
7 world-class cities riding tall in bike-share boom, solving 'the last mile' without cars
ITDP issues first-ever planning guide to shape the next wave of bike-share systems; More than 400 ...
Feeding by tourists compromises health of already-endangered iguanas, study finds
2013-12-06
Feeding by tourists compromises health of already-endangered iguanas, study finds
Feeding wildlife is an increasingly common tourist activity, but a new study published online today by the journal Conservation Physiology shows that already-imperilled iguanas ...
Eating healthy vs. unhealthy diet costs about $1.50 more per day
2013-12-06
Eating healthy vs. unhealthy diet costs about $1.50 more per day
Meta-analysis pinpoints the price difference of consuming a healthy diet, which could be burden for low-income families but is trivial compared with health costs of eating an unhealthy diet
Boston, ...
JILA team develops 'spinning trap' to measure electron roundness
2013-12-06
JILA team develops 'spinning trap' to measure electron roundness
BOULDER, Colo. — JILA researchers have developed a method of spinning electric and magnetic fields around trapped molecular ions to measure whether the ions' tiny electrons are truly ...
UEA research gives first in-depth analysis of primate eating habits
2013-12-06
UEA research gives first in-depth analysis of primate eating habits
From insect-munching tamarins to leaf-loving howler monkeys, researchers at the University of East Anglia (UEA) have compiled the most thorough review of primate eating habits to date.
Findings ...
LAST 30 PRESS RELEASES:
AI language models sharpen chest CT diagnoses, speeding surgical decisions
Machine learning model predicts which patients with nasopharyngeal cancer respond to radiation
GenAI models extract pathological features for lung adenocarcinoma grading and prognosis
New research further investigates safety of general anesthesia in infants
We might inhale 68,000 lung-penetrating microplastics daily in our homes and cars – 100x previous estimates
Indian adults who move to cities are significantly more likely to become obese than their rural counterparts - and the longer they stay, the greater the risk
Instagram images could influence public opinion on certain major events
Different dimensions of psychopathy might be associated with different physiological underpinnings of facial emotion recognition - and oxytocin could affect this skill - per scoping review of 66 studi
How cumulative heat exposure affects students
An international survey of over 300 adults reveals that males born in summer are potentially more prone to depression than those born in other seasons
The unusual head of a fish and the puzzle of its genes
How does metformin lower blood sugar?
Increasing solar power could lead to significant cuts in CO2 emissions
Black Death offers window into how childhood malnutrition affects adult health
Clinical trial finds safe, effective treatment for children with severe post-Covid syndrome
Researchers map where solar energy delivers the biggest climate payoff
Carbon fiber boosts dry-processed battery performance
Influenza-associated acute necrotizing encephalopathy in US children
Rainy tropics could face unprecedented droughts as an Atlantic current slows
‘One and done’: A single shot at birth may shield children from HIV for years, study finds
New method for detecting neutrinos
Respiratory viruses can wake up breast cancer cells in lungs
Stroke center certification and within-hospital racial disparities in treatment
Mortality among surgeons in the United States
Carbon 'offsets' aren't working. Here's a way to improve nature-based climate solutions
Preserving and promoting clinical trial representativeness
Study reveals mixed impact of state e-cigarette flavor bans on tobacco use
McMaster research offers promising new treatment for liver cancer
Most US adults have hearts older than their actual age. How old is yours?
JMIR Biomedical engineering invites submissions on voice phenotyping and vocal biomarkers
[Press-News.org] Brain cancer cells hide while drugs seekTumor cells temporarily lose mutation to evade drugs targeting mutation